N@N

Annidis Corporation Grants Stock Options

^{Published on 2011-09-30 13:54:13 - Market Wire}
 

OTTAWA, Sept. 30, 2011 /CNW/ - Annidis Corporation ("Annidis" or the "Corporation") (TSXV: RHA), creator of the Annidis RHA^TM imaging technology that assists eye-care professionals screen, detect, diagnose and manage ocular diseases, today announced that it has granted an aggregate of 2,000,000 options to directors, officers, employees and consultants of the Corporation. Each option entitles the holder to acquire one Annidis common share at an exercise price of $0.40. These options will expire on September 30, 2016.

Disclaimer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

This news release may contain "forward-looking information" within the meaning of applicable Canadian securities legislation.  Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties.  The words "may", "will", "could", "should", "would", "suspect", "outlook", "believe", "plan", "anticipate", "estimate", "expect", "intend", "forecast", "objective", "hope", and "continue" (or the negative thereof), and words and expressions of similar import are intended to identify forward-looking statements.  Certain material factors or assumptions are implied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.  Factors that could cause results to vary include those identified in the Company's Annual Information Form and other such filings with Canadian securities regulatory authorities, such as the applicability of patents and proprietary technology; possible patent ligation; regulatory approval of products in development; changes in government regulation or regulatory approval processes; government and third party reimbursement; dependence on strategic partnerships; intensifying competition; rapid technological change in the industry; anticipated future losses; the ability to access capital; and the ability to attract and retain key personnel.  All forward-looking information presented herein should be considered in conjunction with such filings.  Except as required by Canadian securities laws, the Corporation does not undertake to update any forward-looking statements; such statements speak only as of the date made.